Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (5)
Type
(
1 selected
)
Type
Guidance (373)
NICE advice (1)
Quality standard (8)
Guidance programme
Guidance programme
Clinical guidelines (25)
Diagnostics guidance (6)
Health technology evaluations (14)
Highly specialised technologies guidance (5)
Interventional procedures guidance (15)
Medical technologies guidance (8)
NICE guidelines (30)
Public health guidelines (1)
Technology appraisal guidance (300)
Apply filters
Showing 341 to 350 of 373
Sort by
Title
Date
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Total hip arthroplasty using the superpath approach for osteoarthritis
Interventional procedures guidance
TBC
Tovorafenib for treating relapsed or refractory paediatric low-grade glioma with BRAF fusion or rearrangement or BRAF V600 mutation in people 6 months and over ID6557
Technology appraisal guidance
TBC
Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: Late stage assessment
Health technology evaluation
21 August 2025
Transcatheter tricuspid valve implantation for tricuspid regurgitation
Interventional procedures guidance
4 March 2026
Transvenous embolisation for treating cerebrospinal fluid venous fistula associated with spontaneous intracranial hypotension
Interventional procedures guidance
25 March 2026
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments [ID6309]
Technology appraisal guidance
TBC
Triheptanoin for treating long-chain fatty acid oxidation disorders [ID3891]
Technology appraisal guidance
TBC
Tucatinib with trastuzumab for previously treated HER2-positive colorectal cancer [ID6227]
Technology appraisal guidance
TBC
Type 2 diabetes in adults: management (medicines update)
NICE guideline
TBC
Upadacitinib for treating giant cell arteritis [ID6299]
Technology appraisal guidance
25 February 2026
Previous page
1
…
33
34
Current page
35
36
37
38
Page
35
of
38
Next page
Results per page
10
25
50
All
Back to top